UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections

Journal of Virology, 2012-06, Vol.86 (12), p.6563-6574

2012

Volltextzugriff (PDF)

Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model

Viruses, 2019-09, Vol.11 (9), p.819

2019

Volltextzugriff (PDF)

Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model

Proceedings of the National Academy of Sciences - PNAS, 2009-04, Vol.106 (17), p.7191-7196

2009

Volltextzugriff (PDF)

An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge

PloS one, 2014-07, Vol.9 (7), p.e100844-e100844

2014

Volltextzugriff (PDF)

Herpes simplex virus growth, preparation, and assay

Methods in molecular biology (Clifton, N.J.), 2014-01, Vol.1144, p.19

2014

Volltextzugriff (PDF)

Heparan Sulfate Proteoglycan Binding by Herpes Simplex Virus Type 1 Glycoproteins B and C, Which Differ in Their Contributions to Virus Attachment, Penetration, and Cell-to-Cell Spread

Journal of Virology, 1998-07, Vol.72 (7), p.6119-6130

1998

Volltextzugriff (PDF)

Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide

Gene therapy, 2004-07, Vol.11 (13), p.1087-1098

2004

Volltextzugriff (PDF)

Inhibition of Herpes Simplex Virus Types 1 and 2 In Vitro Infection by Sulfated Derivatives of Escherichia coli K5 Polysaccharide

Antimicrobial Agents and Chemotherapy, 2008-09, Vol.52 (9), p.3078-3084

2008

Volltextzugriff (PDF)

HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy

Current gene therapy, 2005-10, Vol.5 (5), p.445-457

2005

Volltextzugriff (PDF)

Purinergic Signaling: A New Pharmacological Target Against Viruses?

Trends in pharmacological sciences (Regular ed.), 2018-11, Vol.39 (11), p.926-936

2018

Volltextzugriff (PDF)

HSV-1 Virions Engineered for Specific Binding to Cell Surface Receptors

Molecular therapy, 2004-03, Vol.9 (3), p.419-427

2004

Volltextzugriff (PDF)

HSV as a vector in vaccine development and gene therapy

Human vaccines, 2008-03, Vol.4 (2), p.91-105

2008

Volltextzugriff (PDF)

Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: A preliminary study as possible vaccine against genital herpes

International journal of pharmaceutics, 2013-01, Vol.440 (2), p.229-237

2013

Volltextzugriff (PDF)

Protection from Bacterial Infection by a Single Vaccination with Replication-Deficient Mutant Herpes Simplex Virus Type 1

Journal of Virology, 2004-04, Vol.78 (8), p.4020-4028

2004

Volltextzugriff (PDF)

Herpesvirus/retrovirus chimeric vectors

Current gene therapy, 2004-12, Vol.4 (4), p.409-416

2004

Volltextzugriff (PDF)

An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency

Nucleic acids research, 2007-08, Vol.35 (15), p.e98-e98

2007

Volltextzugriff (PDF)

In Vivo Administration of Replication-Deficient Mutant HSV-1 Targets Professional APCs and Induces Efficient CD4+ T Helper Responses

Retrovirology, 2005-12, Vol.2 (S1), p.P21-P21, Article P21

2005

Volltextzugriff (PDF)

An Attenuated Herpes Simplex Virus Type 1

PloS one, 2014-07, Vol.9 (7)

2014

Volltextzugriff (PDF)

Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors

Trends in neurosciences (Regular ed.), 2000-05, Vol.23 (5), p.183-190

2000

Volltextzugriff (PDF)

Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors

The journal of gene medicine, 2010-12, Vol.12 (12), p.956-967

2010

Volltextzugriff (PDF)

The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells

Experimental cell research, 2004-02, Vol.293 (2), p.331-345

2004

Volltextzugriff (PDF)

APP Processing Induced by Herpes Simplex Virus Type 1

PloS one, 2010-11, Vol.5 (11), p.e13989

2010

Volltextzugriff (PDF)

Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer

Liver international, 2011-11, Vol.31 (10), p.1542-1553

2011

Volltextzugriff (PDF)

Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses

Vaccine, 2006-11, Vol.24 (49), p.7148-7158

2006

Volltextzugriff (PDF)

HSV Recombinant Vectors for Gene Therapy~!2009-12-17~!2010-13-31~!2010-06-17

The open virology journal, 2010-08, Vol.4 (3), p.123-156

2010

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(55)
Buchkapitel
(1)

Sprache

Englisch
(56)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(43)
Humans
(37)
Animals
(26)
Virology
(20)
Biological And Medical Sciences
(18)
Herpes Simplex Virus 1
(17)
Herpesvirus 1, Human - Genetics
(17)
Genetic Vectors
(13)
Herpes Simplex Virus
(13)
Fundamental And Applied Biological Sciences. Psychology
(12)
Mice
(12)
Female
(11)
Vero Cells
(11)
Cell Line
(10)
Medical Sciences
(10)
Microbiology
(10)
Biotechnology & Applied Microbiology
(9)
Gene Therapy
(9)
Herpesvirus 1, Human - Immunology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections

Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model

Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model

An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge

Herpes simplex virus growth, preparation, and assay

Heparan Sulfate Proteoglycan Binding by Herpes Simplex Virus Type 1 Glycoproteins B and C, Which Differ in Their Contributions to Virus Attachment, Penetration, and Cell-to-Cell Spread

Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide

Inhibition of Herpes Simplex Virus Types 1 and 2 In Vitro Infection by Sulfated Derivatives of Escherichia coli K5 Polysaccharide

HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy

Purinergic Signaling: A New Pharmacological Target Against Viruses?

HSV-1 Virions Engineered for Specific Binding to Cell Surface Receptors

HSV as a vector in vaccine development and gene therapy

Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: A preliminary study as possible vaccine against genital herpes

Protection from Bacterial Infection by a Single Vaccination with Replication-Deficient Mutant Herpes Simplex Virus Type 1

Herpesvirus/retrovirus chimeric vectors

An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency

In Vivo Administration of Replication-Deficient Mutant HSV-1 Targets Professional APCs and Induces Efficient CD4+ T Helper Responses

An Attenuated Herpes Simplex Virus Type 1

Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors

Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors

The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells

APP Processing Induced by Herpes Simplex Virus Type 1

Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer

Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses

HSV Recombinant Vectors for Gene Therapy~!2009-12-17~!2010-13-31~!2010-06-17

Suchergebnisse filtern